Glenmark Pharmaceuticals
GLENMARK.NS
#2600
Rank
A$8.42 B
Marketcap
$29.84
Share price
-0.38%
Change (1 day)
103.24%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): $0.17

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is $0.17. In 2022 the company made an earnings per share (EPS) of $0.59 a decrease over its 2021 EPS that were of $0.74.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.17-71.55%
2022$0.59-20.18%
2021$0.747.13%
2020$0.6925.72%
2019$0.55-22.01%
2018$0.7030.15%
2017$0.54-34.82%
2016$0.8363.09%
2015$0.519.68%
2014$0.46-26.58%
2013$0.630.51%
2012$0.63